cdc
initi
surveil
definit
suspect
case
sar
tabl
base
definit
first
publish
definit
specifi
clinic
criteria
requir
potenti
exposur
sar
epidemiolog
link
categor
case
xray
autopsi
evid
pneumonia
respiratori
distress
probabl
other
meet
case
definit
classifi
suspect
case
cdc
initi
categor
case
suspect
april
cdc
adopt
suspect
probabl
classif
sarsaffect
area
constitut
epidemiolog
link
chang
throughout
outbreak
requir
continu
modif
case
definit
cdc
consid
area
sarsaffect
evid
document
suspect
commun
transmiss
exist
region
remov
list
sarsaffect
area
cdcissu
travel
alert
advisori
discontinu
meant
area
report
new
case
sar
day
april
new
coronaviru
sarscov
identifi
etiolog
agent
sar
case
definit
chang
incorpor
criteria
laboratoryconfirm
ill
laboratori
criteria
refin
near
end
outbreak
result
final
case
definit
juli
tabl
revis
requir
convalescentphas
serum
specimen
day
ill
onset
appli
retrospect
consist
instruct
accompani
releas
case
definit
definit
also
introduc
exclus
criterion
suspect
probabl
casepati
confirm
neg
sarscov
infect
analysi
appli
exclus
criterion
allow
complet
present
suspect
probabl
case
captur
monitor
nation
surveil
casepati
elig
inclus
us
resid
present
unit
state
ill
nonu
resid
becam
ill
sar
diagnos
unit
state
monitor
patient
special
interest
april
includ
surveil
us
citizen
present
unit
state
period
ill
includ
surveil
nation
surveil
began
march
day
cdc
initi
emerg
respons
analysi
report
cover
period
march
juli
week
declar
global
outbreak
case
definit
distribut
state
local
health
depart
cdc
epidem
inform
exchang
epix
secur
commun
network
public
health
profession
cdc
health
alert
network
case
definit
also
post
cdc
web
site
dedic
sar
case
report
form
develop
collect
demograph
clinic
data
well
inform
epidemiolog
link
form
also
distribut
epix
electron
mail
council
state
territori
epidemiologist
cste
membership
case
report
form
modifi
outbreak
evolv
begin
outbreak
health
depart
request
report
cdc
respiratori
ill
thought
evalu
sar
although
commun
chain
report
ill
health
depart
vari
state
health
depart
reli
passiv
report
clinician
rather
activ
seek
identifi
potenti
case
cdc
host
weekli
teleconfer
state
local
health
depart
address
develop
issu
relat
domest
surveil
respons
atlantabas
cdc
team
receiv
ill
report
telephon
fax
state
local
health
depart
personnel
collect
data
complet
case
report
form
determin
case
statu
consult
cdc
patient
met
case
definit
data
person
ad
line
list
updat
analyz
daili
hospit
casepati
activ
monitor
establish
outcom
person
pend
data
could
alter
case
statu
ill
fail
meet
case
definit
subsequ
investig
eg
patient
travel
histori
clarifi
remov
line
list
data
collect
system
health
depart
cdc
paperbas
rather
electron
onlin
epidemiolog
data
enter
cdc
electron
databas
merg
laboratori
data
state
local
health
depart
ask
collect
acut
convalescentphas
serum
stool
specimen
nasopharyng
oropharyng
swab
sampl
casepati
caus
sar
establish
specimen
test
wide
array
bacteri
viral
pathogen
cdc
sarscov
discov
serum
specimen
test
sarscov
antibodi
respiratori
stool
specimen
test
sarscov
polymeras
chain
reaction
pcr
diagnost
test
initi
central
cdc
later
reagent
sarscov
antibodi
nucleic
acid
test
made
avail
state
public
health
laboratori
laboratori
respons
network
meet
us
food
drug
administr
requir
use
nonlicens
test
laboratori
cdc
develop
informedcons
document
inform
materi
clinician
use
collect
specimen
sarcov
test
patient
casepati
classifi
confirm
neg
undetermin
sarscov
infect
tabl
juli
period
requir
convalescentphas
specimen
extend
day
newli
identifi
case
basi
evid
seroconvers
sometim
occur
day
cours
outbreak
test
altern
caus
could
fulli
explain
patient
ill
order
discret
local
clinician
sar
often
exclud
basi
local
interpret
test
result
mani
ill
never
report
cdc
diagnost
test
altern
agent
perform
cdc
earli
outbreak
addit
evalu
acut
respiratori
specimen
pair
serum
specimen
suspect
probabl
casepati
evid
follow
respiratori
pathogen
complet
outbreak
mycoplasma
pneumonia
streptococcu
pneumonia
chlamydia
pneumonia
c
psittaci
legionella
pneumophila
influenza
virus
type
b
respiratori
syncyti
viru
parainfluenza
virus
type
human
metapneumoviru
hmpv
adenoviru
pneumonia
immunoglobulin
ig
g
igm
antibodi
measur
use
remel
mycoplasma
pneumonia
iggigm
antibodi
test
system
remel
inc
lenexa
ks
pneumonia
igg
antibodi
pneumococc
surfac
adhesin
protein
psaa
measur
use
psaaelisa
enzymelink
immunosorb
assay
previous
describ
rise
igg
antibodi
titer
twofold
acut
convalescentphas
serum
pair
consid
posit
pneumococc
exposur
event
chlamydia
igg
igm
antibodi
measur
use
microimmunofluoresc
antibodi
assay
focu
technolog
cypress
ca
l
pneumophila
antibodi
measur
use
indirect
immunofluoresc
antibodi
assay
specif
igg
antibodi
respiratori
virus
exclud
influenza
measur
use
indirect
enzym
immunoassay
panel
follow
procedur
previous
describ
hmpv
rise
igg
antibodi
titer
fourfold
greater
acut
convalescentphas
serum
pair
consid
posit
recent
viru
infect
serolog
analysi
influenza
perform
hemagglutinationinhibit
assay
serum
specimen
treat
receptordestroy
enzym
remov
nonspecif
inhibitor
test
specimen
follow
sourc
test
pcr
evid
bacteri
viral
infect
bronchoalveolar
fluid
sputum
tracheal
aspir
nasal
wash
nasal
nasopharyng
oropharyng
swab
sampl
bacteri
method
use
describ
previous
except
l
pneumophila
realtim
pcr
assay
appendix
total
nucleic
acid
extract
specimen
use
qiaamp
viru
biorobot
mdx
kit
qiagen
inc
valencia
ca
revers
transcriptas
rt
assay
influenza
b
virus
respiratori
syncyti
viru
human
parainfluenza
virus
hmpv
perform
previous
describ
rtpcr
assay
adenoviru
picornaviru
inclus
rhinoviru
enteroviru
perform
use
amplif
condit
primer
pair
conserv
region
hexon
gene
region
adenoviru
ac
tt
ct
gct
c
gt
picornaviru
ct
nucleic
acid
extract
also
test
rtpcr
gapdh
housekeep
gene
ensur
rna
integr
absenc
rtpcr
inhibitor
number
ill
report
highest
first
week
surveil
vari
cours
outbreak
figur
among
suspect
probabl
case
complet
critic
surveil
variabl
relat
case
definit
sever
ill
follow
date
symptom
onset
radiolog
chest
imag
pneumonia
hospit
statu
hospit
discharg
date
admit
casepati
healthcar
worker
occup
although
collect
convalescentphas
sera
essenti
assess
infect
sarscov
sampl
need
definit
laboratori
determin
case
statu
obtain
patient
probabl
casepati
suspect
casepati
chisquar
p
sensit
refer
proport
sarscov
case
popul
detect
surveil
system
sarscov
confirmatori
laboratori
test
perform
patient
identifi
surveil
system
evalu
sensit
system
overal
limit
analysi
popul
suspect
probabl
case
definit
laboratori
result
n
evalu
sensit
probabl
case
definit
confirm
patient
n
classifi
probabl
case
lead
sensit
predict
valu
posit
refer
proport
report
case
actual
healthrel
event
surveil
sarscov
infect
predict
valu
posit
among
case
definit
laboratori
result
predict
valu
posit
among
probabl
case
definit
laboratori
result
unit
state
one
mani
countri
report
sar
case
establish
intern
case
definit
report
standard
although
flexibl
limit
need
maintain
harmon
intern
surveil
us
surveil
remain
flexibl
enough
incorpor
frequent
modif
rapidli
exampl
mainland
china
ad
list
sarsaffect
area
within
hour
casepati
travel
provinc
guangdong
ad
line
list
travel
mainland
china
quickli
becam
common
travel
exposur
figur
median
time
symptom
onset
report
suspect
probabl
case
cdc
decreas
first
week
nation
surveil
day
week
median
time
nation
report
increas
median
day
case
report
day
ill
onset
data
date
ill
report
local
state
health
depart
collect
among
suspect
probabl
casepati
serolog
pcr
test
perform
cdc
demonstr
evid
least
one
altern
respiratori
infect
among
specimen
test
picornaviru
enterovirusrhinoviru
common
pathogen
identifi
follow
human
influenza
b
viru
pneumonia
tabl
patient
probabl
suspect
case
sar
equal
like
altern
caus
identifi
casepati
unknown
sarscov
statu
also
equal
like
altern
caus
identifi
respect
adequ
specimen
avail
two
eight
casepati
one
also
show
fourfold
greater
rise
antibodi
influenza
b
us
emerg
public
health
respons
sar
unexplain
respiratori
ill
report
state
local
health
depart
cdc
countless
addit
ill
investig
rapidli
rule
sar
state
local
health
depart
despit
larg
surveil
burden
discoveri
etiolog
agent
sar
develop
effect
diagnost
test
show
unit
state
experienc
limit
sar
activ
global
outbreak
similar
much
europ
africa
australia
south
america
evid
commun
transmiss
unit
state
even
though
sarsaffect
countri
common
travel
destin
us
resid
investig
close
contact
eight
us
patient
yield
one
instanc
secondari
domest
transmiss
although
travelrel
exposur
definit
exclud
case
sourc
exposur
consid
undetermin
addit
healthcar
worker
identifi
nation
surveil
laboratori
evid
sar
infect
despit
evid
unprotect
exposur
confirm
casepati
effect
surveil
time
infectioncontrol
measur
like
help
limit
transmiss
unit
state
experienc
sarscov
infect
despit
opportun
import
spread
remain
unclear
nation
surveil
emerg
respons
met
import
surveil
object
identifi
ill
cluster
investig
track
progress
epidem
unit
state
facilit
specimen
collect
suspect
probabl
casepati
sar
diagnosi
surveil
allow
rapid
frequent
updat
healthcar
public
health
commun
public
statu
outbreak
despit
success
system
sever
import
limit
like
passiv
system
reli
astut
healthcar
provid
detect
report
ill
might
sar
lack
rapid
diagnost
test
could
reliabl
diagnos
sarscov
infect
earli
phase
ill
increas
workload
anxieti
clinician
public
health
personnel
patient
contact
gener
public
frequent
laborintens
contact
healthcar
provid
need
obtain
updat
clinic
inform
report
casepati
result
classif
patient
suspect
probabl
casepati
dynam
often
chang
new
inform
becam
avail
situat
sometim
creat
seem
discrep
nation
state
local
health
depart
case
count
turn
complic
public
commun
evolut
worldwid
outbreak
requir
frequent
modif
case
definit
establish
consist
criteria
defin
sarsaffect
area
basi
commun
transmiss
difficult
final
paperbas
report
system
increas
difficulti
report
cdc
delay
timeli
report
result
databas
allow
state
immedi
access
inform
time
diseas
onset
report
cdc
increas
latter
phase
outbreak
increas
report
lag
may
reflect
grow
surveil
workload
outbreak
progress
delay
report
altern
diagnos
evalu
decreas
sens
urgenc
fuel
low
diseas
rate
low
likelihood
confirm
sar
among
us
casepati
lack
evid
commun
transmiss
valu
remain
vigil
throughout
stage
outbreak
underestim
critic
context
outbreak
infectioncontrol
measur
rapidli
implement
suspect
probabl
casepati
sinc
singl
case
area
could
quickli
global
impact
evid
toronto
hong
kong
hanoi
singapor
taiwan
suggest
circumst
singl
patient
led
larg
number
secondari
case
chain
transmiss
moreov
although
patient
sar
show
radiograph
evid
pneumonia
observ
confirm
us
casepati
sarscov
diseas
outbreak
set
heighten
vigil
infectioncontrol
measur
maintain
suspect
well
probabl
casepati
grow
evid
small
proport
patient
may
exhibit
evid
pneumonia
featur
pneumonia
often
develop
day
ill
timeli
infectioncontrol
measur
implement
us
casepati
could
assess
relev
data
collect
part
nation
surveil
clinic
sign
symptom
sar
infect
similar
respiratori
ill
empir
manag
patient
respiratori
ill
limit
state
local
capac
perform
reliabl
respiratori
diagnost
lack
nation
surveil
respiratori
syndrom
pneumonia
complic
challeng
rapid
identif
sar
patient
comprehens
test
varieti
respiratori
pathogen
among
patient
suspect
probabl
case
found
evid
possibl
infect
bacteri
viral
respiratori
pathogen
sarscov
find
one
casepati
confirm
sarscov
also
test
posit
influenza
b
infect
consist
accumul
evid
coinfect
involv
sarscov
bacteri
viral
respiratori
pathogen
occur
underscor
import
obtain
convalescentphas
serum
sampl
make
final
determin
infect
sarscov
maintain
infectioncontrol
measur
despit
identif
altern
agent
moreov
determin
altern
diagnos
strength
epidemiolog
exposur
criteria
sar
specif
diagnost
test
compat
clinic
sign
symptom
cours
ill
altern
diagnosi
taken
account
tabl
test
respiratori
pathogen
could
complet
outbreak
preclud
time
reassess
casepati
determin
agent
sarscov
like
respons
clinic
ill
help
facilit
time
diagnost
evalu
cdc
plan
develop
realtim
pcr
assay
import
respiratori
pathogen
use
public
health
laboratori
improv
local
capac
diagnos
respiratori
ill
strengthen
nation
prepared
respiratori
ill
threat
june
council
state
territori
epidemiologist
cste
ad
respiratori
ill
due
sarscov
list
nation
report
diseas
cdc
adopt
case
definit
detail
cste
posit
statement
new
definit
updat
octob
improv
predict
valu
posit
nation
surveil
consid
report
investig
requir
monitor
infect
control
separ
case
confirm
sarscov
diseas
report
nation
system
statement
set
stage
futur
sar
surveil
cdc
develop
sar
prepared
plan
unit
state
outlin
detail
recommend
surveil
part
prepared
effort
webbas
surveil
modul
sarscov
diseas
report
place
absenc
recogn
sar
case
initi
surveil
like
consist
sentinel
case
detect
focu
unexplain
ill
healthcar
worker
travel
return
area
affect
sar
recent
global
outbreak
hospit
experienc
high
rate
transmiss
affect
area
infectioncontrol
team
may
addit
institut
passiv
activ
surveil
pneumonia
fever
among
staff
patient
combin
diagnost
test
sarscov
intens
surveil
effort
need
tailor
degre
local
transmiss
within
commun
healthcar
facil
contact
trace
rapidli
identifi
possibl
earli
case
secondari
sar
unrecogn
sourc
infect
person
without
epidemiolog
link
challeng
remain
includ
best
alloc
limit
public
health
resourc
prepared
plan
light
world
limit
experi
sar
infect
synchron
nation
case
definit
report
requir
system
establish
intern
agenc
although
whether
sar
becom
recur
problem
unclear
lesson
learn
prepar
eventu
import
global
infecti
diseas
outbreak
